To explore evolving approaches in obesity management that extend beyond BMI-focused evaluation, emphasizing the role of obesity-related complications and comprehensive clinical assessment in enabling more personalized and effective patient care. Highlights of the webinar 1-12 Confidentiality Notice - This material (including any link) is intended s

Obesity is the most prevalent chronic disease worldwide, affecting millions. Treatments that achieve meaningful weight reduction may improve clinical outcomes in individuals living with obesity. Disclaimer: This information is intended for Health Care Professionals only. This content is approved by Eli Lilly and company (“Lilly”). This content is i

Eli Lilly invites you to an exclusive webinar on Gulf Case Connect Tackling the Cardiometabolic Continuum Obesity is a multifactorial chronic disease influenced by genetic, environmental, physiological, and psychosocial factors, and it serves as a gateway to several noncommunicable diseases. It is recognized by the WHO as a chronic complex disease,

MERCK Digital Engagement Center invites you to an exclusive CME-accredited interactive webinar, “PCOS at the Heart of Women’s Health,” a multidisciplinary online symposium bringing gynecology and endocrinology together to explore PCOS across the continuum of women’s health, from reproductive presentation and fertility considerations to metabolic bu

We are pleased to invite you to our upcoming interactive webinar on- “Precision Medicine in Hypothyroidism,” to gain insights on how to move beyond the one size fits all approach in hypothyroidism to elevate clinical decision-making. Our renowned speaker, Dr. Mohammed Almehthel is a leading researcher and clinician in diabetes, cell replacement the

Introduction Diabetic kidney disease (DKD) is a common and serious complication of type 2 diabetes, contributing significantly to chronic kidney disease progression, end-stage kidney disease, and increased cardiovascular morbidity and mortality (1). Despite advances in standard-of-care therapies, including renin–angiotensin (RAS) inhibitors, SGLT2

Eli Lilly invites you to an expert-led webinar A New Start in Obesity Care: Clinical Insights on Join leading experts in this webinar as they explore the evolving landscape of obesity management and introduce Foundayo, the first and only oral GLP-1 receptor agonist approved for chronic weight management. Session Insights at a Glance: ➤ Obesity as a

Eli Lilly invites you to an exclusive webinar on MedCASE: Translating Evidence into Real‑World Clinical Decisions MedCASE is a case-based medical education initiative that enables scientific exchange through real-world clinical scenarios. Highlights of the Webinar Focused on Obesity and Type 2 Diabetes, the webinar explores multiple case scenarios,

Emerging prescribing trends in obesity management reflect growing interest in oral therapeutic options, driven by patient preference for non-injectable treatments and advancements in drug development. The availability of newer oral agents with improved efficacy profiles is influencing clinician adoption, particularly in patients seeking convenient